Skip to main content

Glenview Trust Co

Bank

Position in NVS — Novartis AG

CIK 1691827 Louisville, KY

Position in NVS

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$265,013
+$16,184 QoQ
Shares Held
1,691
+3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,196
of 1,603 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. NVS ranks #12 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $265,013 1,691
2026-03-31 $248,829 1,629
2025-12-31 $214,249 1,554
2025-09-30 $455,764 3,554
2025-06-30 $459,838 3,800
2025-03-31 $414,259 3,716
2024-12-31 $361,506 3,715
2024-09-30 $426,379 3,707
2024-06-30 $393,369 3,695
2024-03-31 $334,395 3,457
2023-12-31 $341,177 3,379
2023-09-30 $333,795 3,277
2023-06-30 $342,791 3,397
2023-03-31 $312,524 3,397
2022-12-31 $308,175 3,397
2022-09-30 $258,205 3,397
2022-06-30 $287,148 3,397
2022-03-31 $308,967 3,521
2021-12-31 $307,981 3,521
2020-03-31 $220,306 2,672